Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.

Wegner CS, Hauge A, Gaustad JV, Andersen LMK, Simonsen TG, Galappathi K, Rofstad EK.

Acta Oncol. 2017 Jun 29:1-9. doi: 10.1080/0284186X.2017.1343494. [Epub ahead of print]

PMID:
28661213
2.

Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts.

Andersen LMK, Wegner CS, Simonsen TG, Huang R, Gaustad JV, Hauge A, Galappathi K, Rofstad EK.

Oncotarget. 2017 Jul 18;8(29):48060-48074. doi: 10.18632/oncotarget.18231.

3.

Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts.

Gaustad JV, Simonsen TG, Andersen LMK, Rofstad EK.

BMC Cancer. 2017 Jun 12;17(1):411. doi: 10.1186/s12885-017-3404-4.

4.

Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.

Lund KV, Simonsen TG, Kristensen GB, Rofstad EK.

Acta Oncol. 2017 May;56(5):675-681. doi: 10.1080/0284186X.2017.1294762. Epub 2017 Feb 28.

PMID:
28447564
5.

The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles.

Gaustad JV, Simonsen TG, Andersen LM, Rofstad EK.

Transl Oncol. 2017 Apr;10(2):158-167. doi: 10.1016/j.tranon.2016.12.007. Epub 2017 Feb 3.

6.

Properdistatin inhibits angiogenesis and improves vascular function in human melanoma xenografts with low thrombospondin-1 expression.

Gaustad JV, Simonsen TG, Andersen LM, Rofstad EK.

Oncotarget. 2016 Nov 22;7(47):76806-76815. doi: 10.18632/oncotarget.12695.

7.

Functional intratumoral lymphatics in patient-derived xenograft models of squamous cell carcinoma of the uterine cervix: implications for lymph node metastasis.

Rofstad EK, Huang R, Galappathi K, Andersen LM, Wegner CS, Hauge A, Gaustad JV, Simonsen TG.

Oncotarget. 2016 Aug 30;7(35):56986-56997. doi: 10.18632/oncotarget.10931.

8.

Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content.

Wegner CS, Gaustad JV, Andersen LM, Simonsen TG, Rofstad EK.

J Transl Med. 2016 Jun 7;14(1):161. doi: 10.1186/s12967-016-0920-y.

9.

Intracranial Tumor Cell Migration and the Development of Multiple Brain Metastases in Malignant Melanoma.

Simonsen TG, Gaustad JV, Rofstad EK.

Transl Oncol. 2016 Jun;9(3):211-8. doi: 10.1016/j.tranon.2016.04.003. Epub 2016 May 17.

10.

Patient-derived xenograft models of squamous cell carcinoma of the uterine cervix.

Rofstad EK, Simonsen TG, Huang R, Andersen LM, Galappathi K, Ellingsen C, Wegner CS, Hauge A, Gaustad JV.

Cancer Lett. 2016 Apr 10;373(2):147-55. doi: 10.1016/j.canlet.2016.01.047. Epub 2016 Jan 29.

PMID:
26828134
11.

Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.

Simonsen TG, Gaustad JV, Rofstad EK.

J Exp Clin Cancer Res. 2015 Dec 15;34:150. doi: 10.1186/s13046-015-0264-0.

12.

Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.

Gaustad JV, Simonsen TG, Smistad R, Wegner CS, Andersen LM, Rofstad EK.

BMC Cancer. 2015 Nov 14;15:900. doi: 10.1186/s12885-015-1918-1.

13.

Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.

Lund KV, Simonsen TG, Hompland T, Kristensen GB, Rofstad EK.

Radiother Oncol. 2015 Jun;115(3):379-85. doi: 10.1016/j.radonc.2015.05.001. Epub 2015 May 18.

PMID:
25998804
14.

Thrombospondin-1 domain-containing peptide properdistatin improves vascular function in human melanoma xenografts.

Gaustad JV, Simonsen TG, Andersen LM, Rofstad EK.

Microvasc Res. 2015 Mar;98:159-65. doi: 10.1016/j.mvr.2014.02.005. Epub 2014 Feb 17.

PMID:
24555949
15.

Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.

Gaustad JV, Pozdniakova V, Hompland T, Simonsen TG, Rofstad EK.

J Exp Clin Cancer Res. 2013 Nov 19;32:93. doi: 10.1186/1756-9966-32-93.

16.

Tumors exposed to acute cyclic hypoxia show increased vessel density and delayed blood supply.

Gaustad JV, Simonsen TG, Roa AM, Rofstad EK.

Microvasc Res. 2013 Jan;85:10-5. doi: 10.1016/j.mvr.2012.11.002. Epub 2012 Nov 12.

PMID:
23154277
17.

Tumor-line specific causes of intertumor heterogeneity in blood supply in human melanoma xenografts.

Simonsen TG, Gaustad JV, Leinaas MN, Rofstad EK.

Microvasc Res. 2013 Jan;85:16-23. doi: 10.1016/j.mvr.2012.11.001. Epub 2012 Nov 10.

PMID:
23149341
18.

Vascular abnormalities associated with acute hypoxia in human melanoma xenografts.

Simonsen TG, Gaustad JV, Leinaas MN, Rofstad EK.

Radiother Oncol. 2012 Oct;105(1):72-8. doi: 10.1016/j.radonc.2012.08.018. Epub 2012 Sep 27.

PMID:
23022175
19.

Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts.

Gaustad JV, Simonsen TG, Leinaas MN, Rofstad EK.

BMC Cancer. 2012 Sep 4;12:388. doi: 10.1186/1471-2407-12-388.

20.

High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts.

Simonsen TG, Gaustad JV, Leinaas MN, Rofstad EK.

PLoS One. 2012;7(6):e40006. doi: 10.1371/journal.pone.0040006. Epub 2012 Jun 29.

Supplemental Content

Loading ...
Support Center